ArticleCureus2026

Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico.

Grecia Zavala Villafuerte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.